The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(Methylthio)phenyl)-2-phenylquinazolin-4-amine ID: ALA4447490
PubChem CID: 16092354
Max Phase: Preclinical
Molecular Formula: C21H17N3S
Molecular Weight: 343.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CSc1cccc(Nc2nc(-c3ccccc3)nc3ccccc23)c1
Standard InChI: InChI=1S/C21H17N3S/c1-25-17-11-7-10-16(14-17)22-21-18-12-5-6-13-19(18)23-20(24-21)15-8-3-2-4-9-15/h2-14H,1H3,(H,22,23,24)
Standard InChI Key: HQOYRLKAIJOQPD-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
17.9603 -11.2343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9591 -12.0538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6672 -12.4628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6654 -10.8254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3740 -11.2307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3748 -12.0497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0833 -12.4568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7916 -12.0459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7868 -11.2238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0777 -10.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0734 -10.0033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7789 -9.5909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4842 -9.9991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1893 -9.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1854 -8.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4705 -8.3648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7684 -8.7788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4973 -12.4477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4991 -13.2660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2076 -13.6718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9147 -13.2604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9089 -12.4390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1999 -12.0369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8989 -9.9927 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.9029 -10.8098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
8 18 1 0
14 24 1 0
24 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 343.46Molecular Weight (Monoisotopic): 343.1143AlogP: 5.76#Rotatable Bonds: 4Polar Surface Area: 37.81Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.20CX LogP: 6.37CX LogD: 6.37Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.48Np Likeness Score: -1.69
References 1. Krapf MK, Wiese M.. (2016) Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)., 59 (11): [PMID:27148793 ] [10.1021/acs.jmedchem.6b00330 ]